Why I Won't Stop Loading Up on This Terrific ETF

Schwab U.S. Dividend Equity ETF (SCHD) is highlighted as a low-cost dividend ETF with a 0.06% expense ratio, 100 holdings, and a 13.28% annualized return since inception in 2011. The fund has delivered 29.00% over 1 year, 12.88% over 10 years, and its holdings yield 3.4% on average with 9.4% average annual dividend growth over the past five years. The article is broadly supportive of SCHD as a diversified income vehicle, but it is primarily an opinion piece rather than new market-moving news.

Analysis

The real signal here is not “buy the dividend ETF,” but that the market is still paying up for quality cash-return streams while rates remain high and growth leadership is increasingly concentrated. In that environment, SCHD functions as a systematic quality screen with an embedded factor tilt toward firms that can self-fund buybacks and dividend growth, which tends to hold up better in late-cycle or range-bound equity regimes. The second-order effect is that it can become a passive sink for capital rotating out of crowded megacap growth if investors want equity exposure without paying full multiple risk.

TXN is the most important underlying here because it is a dividend-growth proxy with cyclicality that is now being masked by a sharp earnings/FCF rebound. If that rebound persists for another 2-3 quarters, the stock can continue to outperform broader dividend baskets because the market will re-rate it from “income compounder” to “cyclical growth + capital return,” which is a meaningfully better factor mix. The flip side is that SCHD’s one-time annual rebalance can lag inflections; if semiconductor momentum broadens, the ETF may undercapture upside versus owning TXN directly or via a basket of dividend growers with operating leverage.

Consensus may be underestimating rate sensitivity. A low-expense dividend ETF looks attractive when cash yields are elevated, but if front-end rates fall 100-150 bps over the next 6-12 months, the valuation support for high-quality dividend payers could expand further, especially for firms with durable payout growth and buybacks. That said, in a softening macro tape, dividend screens also become crowded defensives, so upside may come more from multiple compression resistance than absolute earnings growth.

The best contrarian read is that SCHD is not a “set and forget” income trade; it is a factor expression that can underperform when high-quality cyclicals and mega-cap tech both lead. The article’s performance attribution leans heavily on TXN-style contributors, which means future returns depend on whether the next leg is broad dividend growth or narrow semiconductor leadership. If breadth improves, SCHD should work; if not, direct stock selection will likely outperform it on a risk-adjusted basis.

Key Decisions for Investors

• Long SCHD vs. cash/short-duration Treasuries over the next 3-6 months if the Fed cuts rates: expect dividend equities to benefit from falling discount rates and persistent income demand; stop if 10Y yields re-break higher.
• Overweight TXN versus SCHD for a 6-12 month horizon: TXN offers more operating leverage plus capital returns; the risk/reward is better if semiconductor cycle strength persists, but size smaller due to earnings cyclicality.
• Pair trade: long TXN / short INTC for 6-9 months: TXN has cleaner balance sheet, better payout growth, and stronger FCF conversion; INTC is more execution-sensitive and less able to compound dividends through the cycle.
• If using SCHD as an income sleeve, sell covered calls 30-45 days out against a partial position to monetize elevated income demand and cap upside in a range-bound tape.
• Avoid chasing SCHD after sharp market-wide dividend rotation; prefer scaling in on pullbacks of 3-5% or after rebalance-driven dislocations, when factor crowding typically unwinds.